» Articles » PMID: 38542453

Advances in the Study of Extracellular Vesicles for Bone Regeneration

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Mar 28
PMID 38542453
Authors
Affiliations
Soon will be listed here.
Abstract

Promoting the efficiency of bone regeneration in bone loss diseases is a significant clinical challenge. Traditional therapies often fail to achieve better therapeutic outcomes and shorter treatment times. However, in recent years, extracellular vesicles (EVs) have gained significant attention due to their exceptional osteogenic function in bone regeneration and superior therapeutic effects compared to traditional cell therapy. EVs have emerged as a promising therapy for tissue defect regeneration due to their various physiological functions, such as regulating the immune response and promoting tissue repair and regeneration. Moreover, EVs have good biocompatibility, low immunogenicity, and long-term stability, and can be improved through pretreatment and other methods. Studies investigating the mechanisms by which extracellular vesicles promote bone regeneration and applying EVs from different sources using various methods to animal models of bone defects have increased. Therefore, this paper reviews the types of EVs used for bone regeneration, their sources, roles, delivery pathways, scaffold biomaterials, and applications.

Citing Articles

Advances in the application and research of biomaterials in promoting bone repair and regeneration through immune modulation.

Liu L, Chen H, Zhao X, Han Q, Xu Y, Liu Y Mater Today Bio. 2025; 30():101410.

PMID: 39811613 PMC: 11731593. DOI: 10.1016/j.mtbio.2024.101410.


Effect of primary osteoblast-derived extracellular vesicles on osteoclast differentiation.

Zhang L, Tan J Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(4):434-442.

PMID: 39034117 PMC: 11375487. DOI: 10.3724/zdxbyxb-2024-0148.

References
1.
Liu A, Lin D, Zhao H, Chen L, Cai B, Lin K . Optimized BMSC-derived osteoinductive exosomes immobilized in hierarchical scaffold via lyophilization for bone repair through Bmpr2/Acvr2b competitive receptor-activated Smad pathway. Biomaterials. 2021; 272:120718. DOI: 10.1016/j.biomaterials.2021.120718. View

2.
Xiao Y, Ding Y, Zhuang J, Sun R, Sun H, Bai L . Osteoimmunomodulation role of exosomes derived from immune cells on osseointegration. Front Bioeng Biotechnol. 2022; 10:989537. PMC: 9437288. DOI: 10.3389/fbioe.2022.989537. View

3.
Hu Y, Wang Y, Chen T, Hao Z, Cai L, Li J . Exosome: Function and Application in Inflammatory Bone Diseases. Oxid Med Cell Longev. 2021; 2021:6324912. PMC: 8423581. DOI: 10.1155/2021/6324912. View

4.
Kim H, Choi D, Yun S, Choi S, Kang J, Jung J . Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2011; 11(2):839-49. DOI: 10.1021/pr200682z. View

5.
Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View